ASKA Pharmaceutical Holdings Co.,Ltd.

TSE:4886.T

2187 (JPY) • At close November 5, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) JPY.

202320222021202020192018201720162015201420132012
Assets:
Current Assets:
Cash & Cash Equivalents 16,73814,50512,10310,5147,29411,10710,34614,7615,4626,7244,2693,983
Short Term Investments 5003,4005,0000001,000002,8502,6502,694
Cash and Short Term Investments 17,23817,90517,10310,5147,29411,10710,34614,7615,4629,5746,9196,677
Net Receivables 15,57915,21714,48213,15313,79211,02210,4009,4858,5668,4697,4429,277
Inventory 20,40217,68715,06014,37214,04214,00511,86810,68311,12511,3759,2319,569
Other Current Assets 2,9242,9502,9121,8932,1981,6952,2042,1301,7252,7722,5231,710
Total Current Assets 56,14353,75949,55739,93237,32637,82934,81837,05926,87832,19026,11527,233
Non-Current Assets:
Property, Plant & Equipment, Net 11,26310,79610,93612,67513,53913,57312,12912,82913,80113,10312,40011,889
Goodwill 000000000000
Intangible Assets 2,8774,4656,18311,89313,58415,3323,3343,4913,2965436951,373
Goodwill and Intangible Assets 2,8774,4656,18311,89313,58415,3323,3343,4913,2965436951,373
Long Term Investments 15,65416,4007,22312,5039,79411,05211,74710,4908,96212,20410,2589,290
Tax Assets 5,2631,7172,3763,5133,6702,5782,1111,5081,393000
Other Non-Current Assets 2,112-17,0202,0662,3261,8302,0967493,1488931,8011,985
Total Non-Current Assets 37,16933,37733,73842,65042,91344,36531,41729,06730,60026,74325,15424,537
Total Assets 93,31287,13883,29782,58280,23982,19466,23566,12657,47858,93351,26951,770
Liabilities & Equity:
Current Liabilities:
Account Payables 7,3552,8383,1186,4556,0407,1075,2175,3093,7846,8564,0744,313
Short Term Debt 4,9803,4381,7232,6482,7483,4981,2001,2002,4588081,441608
Tax Payables 2,89673609360001,57081000
Deferred Revenue 1776,1136,0559360001,57081000
Other Current Liabilities 11,4565,2615,1156,6988,3397,3977,7978,1744,6697,2103,7144,987
Total Current Liabilities 23,96817,65016,01116,73717,12718,00214,21416,25310,99214,8749,2299,908
Non-Current Liabilities:
Long Term Debt 4,5059,18512,32313,74713,67112,9701,7502,5003,2505581161,174
Deferred Revenue Non-Current 000000000000
Deferred Tax Liabilities Non-Current 2,56700000000000
Other Non-Current Liabilities 3415,7726,0727,5877,8657,7657,7107,8607,2756,9257,9847,339
Total Non-Current Liabilities 7,41314,95718,39521,33421,53620,7359,46010,36010,5257,4838,1008,513
Total Liabilities 31,38132,60734,40638,07138,66338,73723,67426,61321,51722,35717,32918,421
Equity:
Preferred Stock 049,3140000000000
Common Stock 1,1971,1971,1971,1971,1971,1971,1971,1971,1971,1971,1971,197
Retained Earnings 56,37249,61945,83341,79039,56040,63039,28037,31234,76134,44733,10733,000
Accumulated Other Comprehensive Income/Loss 5,7985,2173,4722,7332,0792,9953,5082,5461,5622,5511,243827
Other Total Stockholders Equity -1,437-50,816-1,611-1,210-1,263-1,366-1,426-1,544-1,559-1,619-1,642-1,680
Total Shareholders Equity 61,93054,53148,89144,51041,57343,45642,55939,51135,96136,57633,90533,344
Total Equity 61,93054,53148,89144,51041,57343,45642,55939,51135,96136,57633,94033,349
Total Liabilities & Shareholders Equity 93,31187,13883,29782,58280,23682,19366,23366,12457,47858,93351,26951,770